Related Experiment Video
Updated: May 14, 2026
05:15
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
Virus-like particles: Bridging immunization and precision drug delivery
Jyoti Gupta1, Prashant Tiwari1, Reetesh Kumar2
1GLA University, Department of Biotechnology, 17km Stone, NH-19, Mathura-Delhi Road, Mathura 281406, India.
Gene
|May 12, 2026
Summary
Virus-like particles (VLPs) are safe, non-replicating viral mimics. These versatile platforms show great promise for developing advanced vaccines and targeted drug delivery systems for infectious diseases and cancer.
Area of Science:
- Biotechnology
- Immunology
- Nanomedicine
Background:
- Virus-like particles (VLPs) are self-assembling protein structures mimicking viruses but lacking genetic material.
- VLPs present repetitive epitopes, effectively stimulating innate and adaptive immune responses.
Purpose of the Study:
- To analyze VLP-induced immune responses and classifications.
- To highlight VLP potential in vaccine development and targeted therapies.
Main Methods:
- Review of VLP structure, immune activation, and applications.
- Analysis of VLP classification (enveloped and non-enveloped).
- Examination of chimeric VLP development for multivalent vaccines and drug delivery.
Main Results:
- VLPs induce robust immune responses, suitable for vaccines against infections and cancers.
- Chimeric VLPs offer adaptable platforms for vaccines and delivery of therapeutics like siRNA and proteins.
- VLPs demonstrate potential in gene editing for genetic disorders.
Conclusions:
- VLPs are revolutionary next-generation vaccine platforms.
- VLPs serve as advanced biological delivery systems for targeted therapies.
- VLP technology holds significant promise for infectious disease prevention and cancer treatment.
More Related Videos
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:51Vaccinations
Overview
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...